Combining cardiac and renal biomarkers to establish a clinical early prediction model for Cardiac surgery-associated acute kidney injury: a prospective observational study
Research Square
2023
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
Background Cardiac surgery-associated acute kidney injury (CS-AKI) is common and associated with poor outcomes. Early prediction of CS-AKI remains challenging. Currently available biomarkers for AKI are serum cystatin C (sCysC) and urinary N-acetyl-β-D-glucosaminidase (uNAG), and common cardiac biomarkers are N-terminal pro B-type natriuretic peptide (NT-proBNP) and cardiac troponin I (cTNI). This study aimed to evaluate the efficacy of these biomarkers in predicting CS-AKI. Methods Adult patients after cardiac surgery were included in this prospective observational study. The clinical prediction model of CS-AKI was established by the least absolute shrinkage and selection operator (LASSO) regression, and the discriminative ability of the model was evaluated by using the area under the curve of the receiver operating characteristic (AUC-ROC), decision curve analysis (DCA), and calibration curves. The risk nomogram was plotted, and the validation cohort was constructed for external validation. Results In the modeling cohort of 689 and the validation cohort of 313, the incidence of CS-AKI was 29.2% and 39.6%, respectively. Predictors screened by LASSO included age, history of hypertension, baseline serum creatinine, coronary artery bypass grafting combined with valve surgery, cardiopulmonary bypass duration, preoperative albumin, hemoglobin, postoperative NT-proBNP, cTNI, sCysC, and uNAG. The ROC-AUC of the constructed clinical prediction model in the modeling cohort and validation cohort were 0.830 (0.800–0.860) and 0.840 (0.790–0.880), respectively, and the calibration and DCA showed good fit and clinical benefit. Conclusions A clinical early prediction model consisting of the immediately postoperative renal biomarkers sCysC and uNAG and the cardiac biomarkers NT-proBNP and cTNI could improve the predictive accuracy of CS-AKI.
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know